Formycon AG (LON:0W4N)
London · Delayed Price · Currency is GBP · Price in EUR 19.82
-1.13 (-5.39%)
At close: Nov 5, 2025
Formycon AG Market Cap
Formycon AG has a market cap or net worth of 310.97 million as of November 6, 2025. Its market cap has decreased by -58.06% in one year.
Market Cap
310.97M
Enterprise Value
295.94M
Revenue
44.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.82
Market Cap Chart
Since June 23, 2011, Formycon AG's market cap has increased from 29.59M to 310.97M, an increase of 950.77%. That is a compound annual growth rate of 17.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 310.97M | -60.00% |
| Dec 30, 2024 | 777.39M | -0.97% |
| Dec 29, 2023 | 784.98M | -32.38% |
| Dec 30, 2022 | 1.16B | 112.32% |
| Dec 30, 2021 | 546.75M | 14.14% |
| Dec 30, 2020 | 479.02M | 75.85% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 191.73B |
| GSK plc | 70.63B |
| Haleon | 31.86B |
| Smith & Nephew | 11.83B |
| ConvaTec Group | 4.74B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.68B |